RJA
DRRX

Raymond James & Associates’s DURECT Corp DRRX Stock Holding History

Raymond James & Associates’s Portfolio DRRX Stock Details DRRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$29.9K Buy
22,330
+200
+0.9% +$284 ﹤0.01% 3908
2024
Q2 		$28.5K Buy
22,130
+3,630
+20% +$4.27K ﹤0.01% 3857
2024
Q1 		$22.4K Buy
18,500
+3,800
+26% +$3.46K ﹤0.01% 3864
2023
Q4 		$8.67K Sell
14,700
-6,150
-29% -$8.77K ﹤0.01% 3802
2023
Q3 		$51.9K Hold
20,850
– – ﹤0.01% 3672
2023
Q2 		$103K Buy
20,850
+2,900
+16% +$14.7K ﹤0.01% 3625
2023
Q1 		$81.3K Buy
17,950
+500
+3% +$2.71K ﹤0.01% 3683
2022
Q4 		$60.4K Sell
17,450
-4,000
-19% -$19K ﹤0.01% 3701
2022
Q3 		$124K Sell
21,450
-4,900
-19% -$29.9K ﹤0.01% 3568
2022
Q2 		$126K Hold
26,350
– – ﹤0.01% 3632
2022
Q1 		$177K Hold
26,350
– – ﹤0.01% 3704
2021
Q4 		$260K Sell
26,350
-700
-3% -$7.73K ﹤0.01% 3536
2021
Q3 		$346K Buy
27,050
+1,100
+4% +$14.9K ﹤0.01% 3314
2021
Q2 		$423K Buy
25,950
+1,500
+6% +$26.2K ﹤0.01% 3211
2021
Q1 		$484K Buy
24,450
+6,600
+37% +$148K ﹤0.01% 3048
2020
Q4 		$369K Hold
17,850
– – ﹤0.01% 2997
2020
Q3 		$305K Sell
17,850
-15
-0.1% -$301 ﹤0.01% 2949
2020
Q2 		$414K Sell
17,865
-7,400
-29% -$163K ﹤0.01% 2722
2020
Q1 		$392K Sell
25,265
-12,835
-34% -$246K ﹤0.01% 2588
2019
Q4 		$1.45M Buy
38,100
+3,800
+11% +$78.3K ﹤0.01% 2037
2019
Q3 		$631K Sell
34,300
-2,000
-6% -$27K ﹤0.01% 2499
2019
Q2 		$237K Sell
36,300
-400
-1% -$2.5K ﹤0.01% 3137
2019
Q1 		$230K Buy
36,700
+1,350
+4% +$9.11K ﹤0.01% 3149
2018
Q4 		$171K Buy
+35,350
New +$308K ﹤0.01% 3190
2017
Q1 		– Sell
-1,880
Closed -$25K – 3314
2016
Q4 		$25K Sell
1,880
-660
-26% -$8.43K ﹤0.01% 3134
2016
Q3 		$35K Hold
2,540
– – ﹤0.01% 3106
2016
Q2 		$31K Sell
2,540
-50
-2% -$642 ﹤0.01% 2916
2016
Q1 		$35K Buy
+2,590
New +$33K ﹤0.01% 2818

Other funds holding DRRX

ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BWCS
Beirne Wealth Consulting Services Shelton, Connecticut $503M AUM 27.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MAM
Montchanin Asset Management Montchanin, Delaware $94.1M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DI
Dalton Investments Las Vegas, Nevada $103M AUM 3.77% 1-Year Est. Return
IIM
Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return

Raymond James & Associates's DRRX Position: Q3 2024 in Review

Raymond James & Associates increased its DURECT Corp (DRRX) stake by 0.9% in Q3 2024, buying an estimated $284 and bringing the position to 22,330 shares worth $29.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3908.

Raymond James & Associates first reported a position in DRRX in Q1 2016 and has held it in 28 quarters since. The position peaked at $1.45M in Q4 2019. 44 funds tracked by Wall St. Rank hold DRRX as of Q3 2024.

  • Raymond James & Associates held 22,330 shares of DURECT Corp worth $29.9K as of Q3 2024.
  • Raymond James & Associates bought 200 DURECT Corp shares in Q3 2024, an estimated $284.
  • DURECT Corp made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3908 holding.
  • Raymond James & Associates first reported a position in DURECT Corp in Q1 2016 and has held it in 28 quarters since.
  • Raymond James & Associates's DURECT Corp position peaked at $1.45M in Q4 2019.
  • 44 funds tracked by Wall St. Rank held DURECT Corp as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.